Patient Guide: A Phase II Study Evaluating Andamertinib in Patients With Locally Advanced or Metastatic NSCLC Harboring EGFR PACC or EGFR L861Q Mutations.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 0 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07336732
Status: NOT_YET_RECRUITING
Condition: Non-Small-Cell Lung Cancer
Phase: PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily